For the millions of Americans currently living with persistent symptoms, specialists at Sports Medicine of the Rockies and the Mayo Clinic suggest a multidisciplinary approach:
: This follows a similar slide by 2025 prospect Will Johnson , who fell to the 47th pick over fears that chronic injuries would shorten his professional career [24]. Chronic
: In January 2025, the FDA approved Journavx (Suzetrigine) , the first non-opioid analgesic for moderate to severe acute pain, signaling a major step toward these new standards [33, 34]. For the millions of Americans currently living with
: Incorporate mindfulness, deep breathing, and positive self-talk to deal with the psychological impact of persistent pain [25, 36]. This is for informational purposes only
This is for informational purposes only. For medical advice or diagnosis, consult a professional. AI responses may include mistakes. Learn more
In late April 2026, the word "chronic" has dominated two very different headlines: the medical evaluations of top NFL prospects and a pivotal shift in how the FDA approaches long-term pain management. 1. The NFL Draft: The "Chronic" Red Dot
